Pharmaceutical composition for treating a brain tumor
AssigneePatentpool Target GmbH
InventorsRenate BURDA, Jenny MÖRTH-KRETSCHMER, Elisabeth SAND, Dirk WEICKMANN
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical composition for the treatment of a brain tumor, comprising in a pharmaceutically effective amount peptide toxin from plants of the genera Dendrocnide and/or Urera and/or Nanocnide and/or Girardinia; and total toxin or parts of the toxin from plants of the genus Laportea as well as the use of the pharmaceutical composition for the treatment of a brain tumor, a process for the preparation of the pharmaceutical composition and a kit of parts comprising the pharmaceutical composition.
Claims15
A pharmaceutical composition for the treatment of a brain tumor comprising in a pharmaceutically effective amount a) peptide toxin from plants of the genus Dendrocnide, plants of the genus Urera, plants of the genus Nanocnide, plants of the genus Girardinia;
- and b) total toxin or peptide toxins from plants of the genus Laportea having a molecular weight of 15 kDa to 100 kDa and the ability to cross the blood-brain barrier.
Dependencies are inferred from the claim text.